NCT05196711Phase 1Status unknown
A Study to Evaluate the Safety of MAX-40070 in Healthy Subjects
A First-in-Human Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of MAX-40070 in Healthy Subjects
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Status unknown
- Declared phase
- Phase 1
- Sponsor
- Maxinovel Pty., Ltd.
- Participants (registry)
- 78
- Start
- February 2022
- Primary completion
- November 2022
- Study completion
- November 2022
- Last registry update
- January 2022
- Countries
- —
Conditions studied: Alopecia Areata
Interventions: MAX-40070, Placebo
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.